<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05007249</url>
  </required_header>
  <id_info>
    <org_study_id>GHR 1169</org_study_id>
    <nct_id>NCT05007249</nct_id>
  </id_info>
  <brief_title>Benefit of the Chalaxie Pedagogical Tool in the Management of Overweight or Obese Children With Intellectual Disability : a Pilot Monocentric Prospective Study.</brief_title>
  <acronym>CHALAXIE</acronym>
  <official_title>Benefit of the Chalaxie Pedagogical Tool in the Management of Overweight or Obese Children With Intellectual Disability : a Pilot Monocentric Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier de la Region de Mulhouse et Sud Alsace</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier de la Region de Mulhouse et Sud Alsace</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to determine the benefit of the Chalaxie pedagogical&#xD;
      evaluation tool in the management of overweight or obese children with intellectual&#xD;
      disability.&#xD;
&#xD;
      Chalaxie is a software developped as a pedagogical evaluation tool. It is used in the&#xD;
      therapeutic education of overweight and obese children and allow the clinican to explore&#xD;
      several skills of the child, such as self-esteem.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives&#xD;
&#xD;
        1. To assess the feasibility of the Chalaxie tool use during a medical visit;&#xD;
&#xD;
        2. To assess the relevance of the Chalaxie tool for the pediatrician;&#xD;
&#xD;
        3. To describe the characteristics of the patients followed at the &quot;Réseau ODE&quot;;&#xD;
&#xD;
        4. To evaluate patient self-esteem.&#xD;
&#xD;
      Conduct of research After receiving written consent from the study participant and parental&#xD;
      authority, the patients will have two visits with the pediatrician during which they will use&#xD;
      the Chalaxie pedagogical evaluation tool. At the first visit, they will use the self-esteem&#xD;
      assessment module. At the second visit (i.e. final visit), which should take place between 3&#xD;
      weeks and 2 months after the first visit, they will use a module of their choice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 28, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-report patient perception questionnaire</measure>
    <time_frame>through study completion, an average of 2 months</time_frame>
    <description>The benefit of the Chalaxie pedagogical evaluation tool will be measured with the patient perception questionnaire completed at the final visit. It consists of seven single choice questions and one open question.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of the visit</measure>
    <time_frame>on enrollment day only</time_frame>
    <description>Duration will be measured from the moment the written consent is obtained until the end of the visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the use of the self-esteem assessment module</measure>
    <time_frame>on enrollment day only</time_frame>
    <description>Duration will be measured from the moment the investigator clicks on the module until the completion of the last question.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician perception questionnaire</measure>
    <time_frame>Through study completion, on enrollment day to the final visit, an average of 2 months</time_frame>
    <description>Clinician perception questionnaire consists of 12 single choice questions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-esteem</measure>
    <time_frame>on enrollment day only</time_frame>
    <description>Self-esteem will be evaluated with the self-esteem assessment module. It consists of 6 questions with a visual scale of 6 emoticons. It also includes a 4-modality question assessing overall self-esteem that is completed by the patient and pediatrician respectively.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pediatric Obesity</condition>
  <arm_group>
    <arm_group_label>Overweight or obese minors with intellectual disability</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Use of the Chalaxie pedagogical evaluation tool</intervention_name>
    <description>Use of the Chalaxie pedagogical evaluation tool during two visits</description>
    <arm_group_label>Overweight or obese minors with intellectual disability</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Minor patient of 11 years of age or older&#xD;
&#xD;
          -  Overweight or obese patient respectively defined as a BMI ≥ IOTF 25 and ≥ IOTF 30&#xD;
&#xD;
          -  Mild intellectual disability defined as intelligence quotient (IQ) ≥ 55 and &lt;70 or (if&#xD;
             IQ unknown) patient in a special education institution (ULIS, IM-PRO)&#xD;
&#xD;
          -  Affiliated or beneficiary of a social security scheme&#xD;
&#xD;
          -  Written consent of the patient and one of the parental authority holder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with a severe autistic disorder&#xD;
&#xD;
          -  Patient who already used the Chalaxie tool during his/her follow-up&#xD;
&#xD;
          -  Difficulties in understanding the instructions for using the software and/or&#xD;
             difficulties in using a computer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fatiha Guemazi-Kheffi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier de la Région de Mulhouse et Sud-Alsace</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fatiha Guemazi-Kheffi, MD</last_name>
    <phone>+33389646308</phone>
    <email>guemazif@ghrmsa.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karen Berthelon, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Emile Muller (GHRMSA)</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fatiha Guemazi-Kheffi, MD</last_name>
      <email>guemazif@ghrmsa.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intellectual disability</keyword>
  <keyword>patient therapeutic education</keyword>
  <keyword>pedagogical evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intellectual Disability</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

